"at-above-post addthis_tool" data-url=" Wouhra, CEO of Lioncroft Wholesale and chairman of Unitas – the UK’s largest ...

The patient-specific nature of autologous cell therapies presents unique challenges that can best be addressed by a middle path between on-site and centralized manufacturing.

Because AI technology is constantly evolving, employers must remain flexible, experts say. “A static AI policy will be ...

These days, artificial intelligence developers, investors and founders are all obsessed with “reinforcement learning,” a ...

The subject in this interview: Rasmus Kjaergaard, the CEO of Mindway AI, a company that merges neuroscience, expert ...

With increasingly complex market dynamics, traditional personalization alone is no longer sufficient. Enter predictive AI ...